Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancersSimona Camorani, Laura Cerchia|Scientific Reports|2017Cited by 93
Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectorsLisa Agnello, Laura Cerchia|Journal of Experimental & Clinical Cancer Research|2021Cited by 82
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancerSimona Camorani, Laura Cerchia|Journal of Experimental & Clinical Cancer Research|2020Cited by 70
Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cellsSimona Camorani, Laura Cerchia|Oncotarget|2015Cited by 67
Frontiers in Drug Design and DiscoveryAtta‐ur Rahman, Florian Wülfert, Williams Jones et al.|Unknown|2006Cited by 49